TradeFlare's AI research teams analysed FDMT on 14 market nights between April 27, 2026 and October 5, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| October 5, 2026 | HOLD | $13.67 | — / — | +0.6% | not yet | The current setup does not meet the criteria for a BUY recommendation. |
| October 2, 2026 | BUY | $13.84 | $15.91 / $11.76 | -2.5% | not yet | The fundamental and sentiment teams are bullish, suggesting a longer-term upward trend, while the technical setup indicates a short-term bounce opportunity. |
| September 14, 2026 | BUY | $13.17 | $16.00 / $11.85 | +10.8% | -5.5% | Mean-reversion from deeply oversold levels toward intermediate moving averages and breakout resistance typically unfolds across a multi-week swing. |
| August 25, 2026 | BUY | $15.39 | $23.09 / $11.54 | -8.7% | -4.6% | The post-earnings drift signal suggests continued upward momentum over the coming weeks. |
| August 24, 2026 | BUY | $15.83 | $19.79 / $13.46 | -8.3% | +3.2% | The post-earnings drift suggests continued upward momentum over the coming weeks. |
| August 22, 2026 | BUY | $15.83 | $20.58 / $13.46 | -8.3% | +3.2% | The post-earnings drift suggests momentum could persist for several weeks. |
| August 21, 2026 | BUY | $16.10 | $20.13 / $13.69 | -7.3% | -3.7% | The post-earnings drift signal suggests momentum could persist for several weeks. |
| July 20, 2026 | BUY | $10.99 | $12.60 / $8.93 | -6.4% | +31.1% | The scanner trigger suggests a short-term mean-reversion opportunity, but the fundamental and sentiment catalysts point to longer-term potential. |
| July 17, 2026 | BUY | $10.84 | — / — | -8.4% | +10.9% | The current market regime is neutral, and while FDMT has strong fundamental support, its technicals are mixed and the risk profile is high, necessitating a HOLD until clearer signals emerge. |
| July 1, 2026 | BUY | $13.30 | $15.80 / $11.31 | +1.6% | -20.6% | The post-earnings drift pattern suggests momentum could persist for several weeks. |
| April 30, 2026 | BUY | $8.81 | — / — | +11.9% | +11.7% | Positive clinical trial updates for gene therapy candidates. |
| April 29, 2026 | BUY | $9.42 | — / — | +18.3% | +1.8% | Positive clinical trial updates for gene therapy |
| April 28, 2026 | SELL | $9.45 | $11.34 / $8.03 | +3.1% | -6.0% | The stock is consolidating near resistance, and while fundamentals are strong, technicals are neutral and risk is high, requiring a clearer signal. |
| April 27, 2026 | HOLD | $9.40 | $11.28 / $7.99 | -0.1% | -7.8% | The neutral market regime and mixed technicals necessitate a cautious approach, waiting for clearer signals or a stronger risk/reward setup. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.